Analyst Information for Rhythm Pharmaceuticals Inc.

$ 21.58   0.80 (+3.85%) Volume: 194.53k 4:00 PM EDT Jul 14, 2020
After Hours:  $ 21.58 0.00 (0.00%) Volume: 1.91k 4:00 PM EDT Jul 14, 2020
Consensus Rating Average
Consensus Rating for RYTM is STRONG BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.13
Previous Average Recommendation 1.08
Change in Average Recommendation 0.05
Number of Analysts Reporting 4
Strong Buy
1.0
Current: 1.13
Previous: 1.08
Change: 0.05
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 397
Rank Recommendation relative to companies in its industry 220
Ranked 220 in Industry
1397 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 3
Analysts recommending Moderate Buy 1
Analysts recommending Hold 0
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 5 5 5
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.13 1.08 1.08 1.08

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.